Microbiology Department, Laboratori Clínic Metropolitana Nord, Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol (IGTP), Badalona (Barcelona), Spain.
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Liver Int. 2022 Aug;42(8):1751-1761. doi: 10.1111/liv.15327. Epub 2022 Jun 14.
Pakistani migrants in Catalonia, Spain, could have high hepatitis C virus (HCV) prevalence. The aims of the HepClink study were (i) to implement and assess the quality of a micro-elimination strategy based on a community intervention and (ii) to obtain data from primary care (PC) registries as a baseline comparator.
The community intervention targeted Pakistani adults and consisted of education, screening and simplified access to treatment. Quality indicators were calculated (effectiveness, impact and acceptability). The testing rate, the prevalence of HCV antibodies and HCV-RNA were compared with those observed in the Pakistani population accessing PC in the previous year.
A total of 505 participants were recruited through the community intervention (64.6% men, median 37 years) vs those accessing PC (N = 25 455, 70.9% men, median 38 years). Among study participants, 35.1% did not know about HCV and 9.7% had been previously tested. The testing rate in the community intervention was 99.4% vs 50.7% in PC. Prevalence was 4.6% vs 7.1% (p = .008) for HCV antibodies and 1.4% (3/6 new diagnoses) vs 2.4% (p = .183) for HCV-RNA. Among the six viremic patients, three began treatment within the intervention and two through the usual circuit and all completed the full course.
This novel community intervention was well accepted and effective at reaching a Pakistani migrant population with a low-level knowledge of HCV and largely not tested before. The observed prevalence and the high unawareness of their HCV status justify a targeted screening in this group both in the community and in PC.
在西班牙加泰罗尼亚的巴基斯坦移民可能具有较高的丙型肝炎病毒(HCV)流行率。HepClink 研究的目的是:(i)实施并评估基于社区干预的微型消除策略的质量,以及(ii)获取来自初级保健(PC)登记处的数据作为基线比较。
社区干预的目标人群是巴基斯坦成年人,包括教育、筛查和简化治疗途径。计算了质量指标(有效性、影响和可接受性)。比较了通过社区干预(64.6%为男性,中位数年龄为 37 岁)和通过 PC 获得治疗(N=25455 例,70.9%为男性,中位数年龄为 38 岁)的参与者的检测率、HCV 抗体和 HCV-RNA 的流行率。
通过社区干预共招募了 505 名参与者(64.6%为男性,中位数年龄为 37 岁),与通过 PC 获得治疗的参与者(N=25455 例,70.9%为男性,中位数年龄为 38 岁)进行比较。在研究参与者中,35.1%不知道 HCV,9.7%曾接受过检测。社区干预的检测率为 99.4%,而 PC 的检测率为 50.7%。HCV 抗体的流行率为 4.6%vsPC 中的 7.1%(p=0.008),HCV-RNA 的流行率为 1.4%(3/6 例新诊断)vsPC 中的 2.4%(p=0.183)。在 6 例病毒血症患者中,3 例在干预期间开始治疗,2 例通过常规途径开始治疗,所有患者均完成了全程治疗。
这种新颖的社区干预措施得到了很好的接受,并且能够有效地接触到丙型肝炎病毒知识水平较低、且之前未接受过大量检测的巴基斯坦移民人群。观察到的流行率以及对 HCV 感染状态的高不知情率证明,在社区和 PC 中都需要对这一人群进行有针对性的筛查。